Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression

[1]  Brooke N. Bullock,et al.  Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma , 2013, Oncogene.

[2]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[3]  Jiewei Chen,et al.  High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma , 2011, Journal of Translational Medicine.

[4]  D. Buggy,et al.  Anaesthesia for cancer patients , 2007, Current opinion in anaesthesiology.

[5]  Paul J van Diest,et al.  p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer. , 2006, Human pathology.

[6]  P. Harrison,et al.  Profiling early head and neck cancer , 2005, Nature Reviews Cancer.

[7]  D. Tindall,et al.  p300 in prostate cancer proliferation and progression. , 2003, Cancer research.

[8]  P. Cole,et al.  Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. , 2002, Cancer research.

[9]  J. Grandis,et al.  Differential function of STAT5 isoforms in head and neck cancer growth control , 2002, Oncogene.

[10]  Y. Kwong,et al.  Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. , 2002, Journal of clinical pathology.

[11]  M. Erdos,et al.  p300 Modulates the BRCA1 inhibition of estrogen receptor activity. , 2002, Cancer research.

[12]  K. Pavelić,et al.  Aberration of FHIT Gene is Associated with Increased Tumor Proliferation and Decreased Apoptosis—Clinical Evidence in Lung and Head and Neck Carcinomas , 2001, Molecular Medicine.

[13]  R. Goodman,et al.  CREB-binding Protein and p300 in Transcriptional Regulation* , 2001, The Journal of Biological Chemistry.

[14]  Z. Wang,et al.  Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. , 2000, Molecular cell.

[15]  R. Goodman,et al.  CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.

[16]  Carlos Caldas,et al.  Mutations truncating the EP300 acetylase in human cancers , 2000, Nature Genetics.

[17]  H. Saito,et al.  Expression of protein p27 is associated with progression and prognosis in laryngeal cancer , 1999, The Laryngoscope.

[18]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[19]  R. Clark,et al.  Midazolam: a review of therapeutic uses and toxicity. , 1997, The Journal of emergency medicine.

[20]  T. Iwama,et al.  p300 gene alterations in colorectal and gastric carcinomas. , 1996, Oncogene.

[21]  J W Dundee,et al.  Midazolam , 1984, Drugs.